img

RESPONSE DASHBOARD

BARDA COVID-19 RESPONSE
Dr. Robert Johnson
BARDA IEIDD Division Director and BARDA COVID-19 Response Lead
Recorded February 9, 2021
Download Video Transcript
BARDA COVID-19 Response Timeline

Partnering Opportunities

Tech Watch

If you are interested in partnering with the federal government on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners.

To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.

EZ BAA

Novel Coronavirus EZ-BAA

To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.

BAA

BARDA is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003).

Our COVID-19 Partnerships

BARDA JUMP-STARTED COVID-19 TESTS

BARDA scientists started working with private-sector partners in January 2020, days after the novel coronavirus was first reported.

BARDA continues to support test development and has expanded support of programs that increase testing speed and capacity for lab tests, as well as broaden access to testing by developing point-of-care and home-use platforms.

EXPLORE THE NUMBER OF COVID-19
VACCINE DOSES DELIVERED BY
BARDA PARTNERS

Join The Fight! Be A Responder

Every American can make a difference in our country's response to COVID-19.
Learn more about how you can contribute to the fight.